Biotech Business

DuPont Strengthens Leading Biotechnology Position with Leadership Changes

Published in Law and Health Weekly, March 15th, 2008

DuPont (NYSE:DD) announced leadership changes to strengthen its leading biotechnology position and better serve the growing global demand for the company's biotech- based innovations in materials, food, feed and fuel markets.

"Across its business segments, DuPont is integrating biology with its expertise in chemistry to deliver its biotechnology pipeline to the marketplace. DuPont has stepped up its efforts, including today's leadership changes, to accelerate commercialization of its bio-based technologies to meet growing global demand," said DuPont Chairman and CEO Charles O. Holliday, Jr.

"Population growth, rising income and demand for bio-based...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2008-03-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry